PME - Pro Medicus Limited

salvation • The sale represents less than 4% of their respective shareholdings • The sale to a number of local institutions was made at th

salvation 17 February 2021 HIGHLIGHTS ▪ Revenue $31.59m – up 7.8% ▪ Underlying profit before tax $18.76m – up 25.9% ▪ Net profit $13.54m –

salvation 16 February 2021 HIGHLIGHTS • PME signs 7-year, A$31M deal with a major academic health systems comprising UCSF, UCLA, UCSD, UC

salvation touched $47.33 today ( a 12 month high ) is currently $46.92 DYOR --------------------------------------------------------------

salvation 2 February 2021 HIGHLIGHTS • First Artificial Intelligence (AI) algorithm developed by PME • Developed using PME’s unique end to

salvation 15 October 2020 HIGHLIGHTS • PME signs 7-year, A$10M deal with LMU Klinikum • LMU Klinikum is one of the largest university hosp

salvation PME signs Research Collaboration agreement with NYU Langone Health 11 September 2020 HIGHLIGHTS • PME signs multi-year Research

salvation 1 June 2020 HIGHLIGHTS • PME signs 5-year, A$22M deal with Northwestern Memorial HealthCare for Visage 7 • Extends PME’s footpri

salvation On 2 April 2019, leading health imaging company Pro Medicus (ASX: PME) announced the implementation of an on-market share buy-fo

salvation 13 February 2020 HIGHLIGHTS  Revenue $29.3m – up 15.7%  Net profit after tax $12.1m – up 32.7%  Underlying profit before tax

salvation 30 December 2019 HIGHLIGHTS ● Visage 7: the cloud-based platform for Nine’s development of future radiology services ● Transacti

salvation 450 Swan Street Richmond VIC 3121 In this Open Briefing®, Sam discusses: o AGM Commentary - ahead of budget year to date plus st

salvation SYDNEY, JULY 31, 2019: S & P Dow Jones Indices announced today that it will remove DuluxGroup Limited (XASX: DLX) from the S & P

salvation https://www.raskmedia.com.au/2019/07/12/youd-be-bonkers-to-buy-pro-medicus-pme-shares-today/ ( DYOR ) i hold PME ( ;free-carried

salvation 10 December 2018 HIGHLIGHTS  German Government Hospital network to extend use of Visage 7 technology  Additional licences for

salvation 20 November 2018 HIGHLIGHTS  PME signs 7 year deal with Partners Healthcare in the USA  Initial rollout to include Massachuset

salvation HIGHLIGHTS  After-tax profit of $12.74 million – up 36.7%  Revenue of $36.02 million – up 13.9%  Underlying profit of $12.57

salvation 28 June 2018 HIGHLIGHTS  Mercy to standardise on Visage 7 Open Archive across its diagnostic imaging business  Industry defini

salvation 1st May 2018 HIGHLIGHTS  I-MED to standardise on Visage RIS across all 200 practices  I-MED’s Regional Imaging (RIL) and Queen

salvation 16 February 2018 HIGHLIGHTS  Revenue of $16.57m – up 9.0%  Underlying after tax profit of $5.42m– up 33.0%  Net profit (after

salvation 18 August 2017 HIGHLIGHTS  Record after-tax profit of $9.32 million – up 46%  Underlying profit after-tax of $9.87 million – u

salvation 14 March 2017 HIGHLIGHTS  Five-year deal with Primary Health Care Limited, one of the largest diagnostic imaging networks in Au

salvation HIGHLIGHTS  After-tax profit of $4.80 million – up 63.1%  Revenue of $15.20 million – up 6.4%  Underlying profit after tax -

salvation Pro Medicus Limited Full-Year Results Friday 19 August 2016 HIGHLIGHTS  After-tax profit $6.37 million – up 98%  Underlyin

salvation Key Points:  PME signs 6 year deal with Mayo Clinic in the US  Visage 7 to be implemented enterprise-wide throughout Mayo Clin

salvation Key Points:  Franciscan Missionaries of Our Lady Health System (FMOLHS) to use Pro Medicus’ Visage 7 technology for primary dia

salvation Key Points: Mercy Health System to use Pro Medicus Visage 7 technology for primary diagnosis and distribution of medical images

salvation On 17 March 2015, Leading health imaging company Pro Medicus (ASX: PME) announced the implementation of an on-market share buy-f

salvation Key Points: Large German Government Hospital to use Visage 7 technology throughout its diagnostic imaging facilities Cross-regio

salvation Key Points: Allegheny Health Network (AHN)to use Pro Medicus Visage 7 technology for primary diagnoses and clinical distribution

salvation 2.1 2015 A$000 / 2014 A$000 /%change Revenue from continuing operations 17,577 ..14,447 ..21.7% Profit/(Loss) from ordinary acti

salvation Leading imaging IT provider,Pro Medicus Limited [ASX: PME], today announced its wholly-owned US subsidiary Visage Imaging Inc ha

salvation PRO MEDIC US (PM) up 21c to $1.75: Announced on Tuesday its US subsidiary Visage Imaging had signed a $9.5m seven-year contract

salvation Key points: First-half net profit increased to $1.61 million from $0.2 million in previous corresponding period Revenue $8.64 mi

salvation PRO MEDICUS (PME) up 6.5c to $1.215: Long Island radiology group and outpatient imaging provider Zwanger-Pesiri will use Pro Med

salvation Key points: WellSpan to use Pro Medicus Visage 7 technology for primary diagnoses and clinical distribution of medical images Se

salvation PRO MEDICUS (PME) up 8c to 95c: Profit from underlying operations was $1.58m, versus a loss of $0.65m. Directors declared a fina

salvation Sydney - Wednesday - April 23: (RWE Aust Business News) LOCAL BIO TECH HEADING FOR BIG TIME IN US MARKETS PRO MEDICUS(PME) has g

salvation PRO MEDICUS (PME) up 7c to 83c: A large US health network is to use Pro Medicus's Visage 7 enterprise imaging platform for prima

salvation Sydney - Friday - February 21 (RWE) - Pro Medicus Limited ( PME) today reported net profit after tax of $0.20 million for the fi

formerUser PME - Company Announcement Pro Medicus signs US$4 million deal with large US Veterans Affairs Network
Pro Medicus first US gov

formerUser Name of entity Pro Medicus Limited ABN 5 006 194 752 Name of Director Peter Terence KEMPEN Date of last notice 20 September 2012

formerUser PME - Appendix 4E - Preliminary Final Report Appendix 4E Preliminary Final Report

formerUser PME - Leading e-health company Pro Medicus [ASX: PME] today announced its wholly-owned subsidiary, Visage Imaging Inc. (Visage),

formerUser PME - Pro Medicus Announces On Market Share Buy Back Pro Medicus announced the implementation of an on-market share buy-back for

formerUser PME - Appendix 4D Appendix 4D Half-Year Report